Get our latest insights direct to your inbox
Sign up for our quarterly newsletter - trends, market intelligence and expert perspectives.

Life sciences are advancing rapidly, driven by breakthroughs in genomics, biologics and advanced therapies. At the same time, AI and digital transformation are speeding up discovery and reshaping lab and production environments. These shifts require new, more adaptable facilities to support faster development cycles and shorter time-to-market.
The challenge is balancing the need for speed with the absolute rigour of a regulated environment. Facilities need to be ready to perform from day one and also resilient enough to evolve as science advances. We help you plan and deliver these complex environments with clarity and control.
We manage projects and portolios for the world's leading pharmaceutical and life science companies, delivering the most complex clinical and industrial builds.
Our global network brings together deep sector expertise with local market knowledge – shaped by thousands of projects across lab and production facilities.
We bring strategy, commercial insight and delivery discipline together – reducing risk, strengthening compliance and bringing certainty to a high-stakes environment.
Our digital platform gives a single source of truth for cost, risk, and schedule – powered by a global data set that sharpens decisions and drives performance at every stage.
We’ve spent decades delivering life sciences facilities – from specialist, high-containment labs to £1bn+ globally significant programmes. Our teams combine rigorous project, cost and risk management with a deep understanding of the regulatory demands that define this sector.
We use industry-leading benchmark data and digital tools to shape programmes from the outset – giving teams a clear view and the insight they need to make confident decisions. This proactive approach extends to the supply chain, where we engage early to secure the specialist expertise needed for controlled environments, ensuring technical precision is matched by commercial value.
Throughout delivery, we maintain clear governance and disciplined cost and schedule control. The result is facilities that are safe, efficient and ready to support the next generation of science.
“There was a very clear vision for ONE BioHub – to create an iconic focal point for commercialisation and growth in the heart of the life sciences ecosystem in Aberdeen, UK. Turner & Townsend and the design team shared the ambition and addressed the project challenges. They understood the purpose of the industry innovation hub, stayed true to the vision from initial design concepts to project completion, and brought it to life by creating a building that is a striking statement of ambition.”
Jennifer Craw
CEO of Opportunity North East (ONE)
Sign up for our quarterly newsletter - trends, market intelligence and expert perspectives.
Sign up for our quarterly newsletter - trends, market intelligence and expert perspectives.